Research program developing biofertilizer protocols for cultivating Cryptolepis sanguinolenta, a medicinal plant, to maximize cryptolepine yield in roots and explore above-ground biomass as a biopesticide against tomato pests and pathogens.
This research program advances the domestication and cultivation of Cryptolepis sanguinolenta (CS), a medicinal plant valued for its cryptolepine content and broad therapeutic properties including antimalarial, antimicrobial, antimycobacterial, and antihyperglycemic effects. The work investigates how nitrogen- and phosphorus-based biofertilizers can enhance root biomass and cryptolepine yield, while also evaluating the above-ground plant material as a potential biopesticide against root-knot nematodes and Fusarium spp. affecting tomato crops.
The program addresses two complementary opportunities: improving the productivity of a high-value medicinal crop through sustainable biofertilization, and repurposing agricultural byproducts (stems and leaves) as natural biocontrol agents. This dual focus offers both pharmaceutical and agricultural value chains an integrated, sustainable production approach.
Cultivation and biofertilization approach:
Prior findings informing the work:
Biopesticide evaluation:
The biofertilizer optimization component is at an early-to-mid validation stage, building on established domestication protocols and prior field validation with inorganic fertilizers. The biopesticide application of above-ground biomass is at an early exploratory stage, with laboratory screening planned for antifungal and nematicidal efficacy. The program requires funding for biofertilizer inputs and materials for extraction and quantification of active ingredients.
The University of Ghana is a comprehensive public research university in Accra, combining broad academic breadth with a strong applied research mission. Industry interfaces through the Institute of Applied Science and Technology, which convenes engagement programs and facilitates contract work, internships, and demonstrations. Clinical translation is enabled by the on‑campus University of Ghana Medical Centre and the Noguchi Memorial Institute for Medical Research, providing advanced laboratories and patient‑adjacent research. Research is supported by competitive Ghanaian government sources and international funders. A dedicated technology transfer and IP unit within the Office of Research, Innovation and Development supports protection, licensing, and industry collaboration agreements.